VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AHCO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AHCOAdaptHealth Corp.
$10.21$1.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAHCOBalance Sheet

AdaptHealth Corp. (AHCO) Balance Sheet

9Y historyFree accessUpdated daily

The company's liquidity position has tightened, with the current ratio declining to 0.92 in 2026Q1, while the balance sheet remains heavily weighted toward $2.6B in goodwill.

AHCO Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Total Current Assets687.48M728.9M755.79M649.02M585.31M670.06M363.25M181.41M1.11M119.82K
Cash & Short-Term Investments47.96M106.14M109.75M77.13M46.27M149.63M99.96M76.88M947.1K119.82K
Cash Only47.96M106.14M109.75M77.13M46.27M149.63M99.96M76.88M947.1K119.82K
Short-Term Investments0000000000
Accounts Receivable391.97M370.9M408.02M388.91M359.15M359.9M171.06M78.62M53.02M0
Days Sales Outstanding50.0541.7245.6744.3644.1353.5259.1154.1856.04-
Inventory159.27M151.25M139.84M113.64M127.75M123.09M58.78M13.24M7.67M4.96M
Days Inventory Outstanding27.9320.6319.7816.4718.2622.3623.8810.969.8211.12
Other Current Assets88.28M098.18M69.34M52.14M000-60.69M0
Total Non-Current Assets3.74B3.59B3.73B3.86B4.63B4.58B1.45B365.12M253.02M190.79K
Property, Plant & Equipment795.08M674.22M618.36M637.53M622.01M546.34M110.47M63.56M61.6M35.57M
Fixed Asset Turnover4.20x4.81x5.27x5.02x4.78x4.49x9.56x8.33x5.61x5.41x
Goodwill2.57B2.54B2.68B2.72B3.55B3.51B998.81M266.79M202.44M38.63M
Intangible Assets80.23M85.12M105.55M130.16M162.77M202.23M116.06M000
Long-Term Investments00000000-276.9M0
Other Non-Current Assets18.8M19.12M17.58M21.13M22.41M15.1M16.48M6.85M253.02M-74.01M
Total Assets4.42B4.32B4.49B4.51B5.22B5.25B1.81B546.54M254.12M310.62K
Asset Turnover0.65x0.75x0.73x0.71x0.57x0.47x0.58x0.97x1.36x619.93x
Asset Growth %-9.58%-3.8%-0.48%-13.62%-0.59%189.53%231.81%115.07%81713%-
Total Current Liabilities743.29M712.39M566.99M537M456.21M499.81M422.05M154.05M699.39K286.31K
Accounts Payable0352.38M284.6M211.5M222.5M248.03M191.04M79.24M40.77K60.51K
Days Payables Outstanding47.4348.0640.2730.6531.8145.0677.665.630.050.14
Short-Term Debt78.27M20.31M16.25M53.37M35M20M8.15M1.72M27.9M174.24K
Deferred Revenue (Current)116.14M034.94M38.57M31.64M31.37M11.04M9.56M7.51M0
Other Current Liabilities665.01M291.27M33.55M14.68M19.86M43.19M126.37M20.3M-27.9M-9.95M
Current Ratio0.92x1.02x1.33x1.21x1.28x1.34x0.86x1.18x1.58x0.42x
Quick Ratio0.71x0.81x1.09x1.00x1.00x1.09x0.72x1.09x-9.39x-16.92x
Cash Conversion Cycle30.5414.2925.1930.1730.5830.825.39-0.4865.81-
Total Non-Current Liabilities2.17B2.08B2.34B2.5B2.61B2.68B1.11B458.27M7.88M54.91M
Long-Term Debt123.53M1.72B1.96B2.09B2.15B2.18B776.57M395.11M127.09M52.7M
Capital Lease Obligations315.64M118.07M104.91M108.28M108.34M120.18M0233.14K172.47K0
Deferred Tax Liabilities000000003.78M0
Other Non-Current Liabilities2.04B243.8M272.02M302.09M344M380.25M334.01M62.92M-119.39M-52.7M
Total Liabilities2.91B2.79B2.91B3.04B3.06B3.18B1.53B612.32M8.57M286.31K
Total Debt201.81M1.9B2.13B2.29B2.33B2.37B807M416.82M155.17M174.24K
Net Debt153.84M1.8B2.02B2.22B2.28B2.22B707.03M339.94M154.22M54.42K
Debt / Equity0.13x1.25x1.35x1.56x1.08x1.15x2.87x-0.62x-
Debt / EBITDA0.40x3.18x3.39x-3.79x4.90x5.25x4.53x3.14x0.01x
Net Debt / EBITDA0.31x3.00x3.21x-3.72x4.59x4.60x3.70x3.12x0.00x
Interest Coverage0.65x0.86x2.07x-4.54x1.89x3.01x-3.97x0.44x7.29x-
Total Equity1.51B1.53B1.58B1.47B2.16B2.07B280.85M-65.78M248.42M-34.07M
Equity Growth %6.35%-3.28%7.6%-32.03%4.41%635.88%526.93%-126.48%829.18%-
Book Value per Share11.1511.2911.6410.9115.5215.545.35-0.917.95-1.09
Total Shareholders' Equity1.51B1.52B1.57B1.46B2.15B2.06B354.89M-38.82M245.55M24.31K
Common Stock14K13K13K13K13K13K9K7K240.55M719
Retained Earnings-649.01M-632.97M-562.18M-652.6M26.3M-43.02M-199.2M-40.26M2.09M-693
Treasury Stock0-25.55M-25.55M-43.27M-13.99M00000
Accumulated OCI078K2.25M4.36M8.69M-2.35M-4.41M1.43M00
Minority Interest7.41M7.76M6.97M8.21M6.6M4.78M-74.04M-26.96M2.87M-34.09M

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

High Debt Refinancing Risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Leverage Profile and Refinancing Vulnerability

As reported in recent financial statements, AdaptHealth's debt structure underwent a significant shift in 2026Q1, with total debt plummeting from $1.9B to $201.8M, a development that warrants close scrutiny to determine if this reflects a permanent deleveraging event or a temporary accounting reclassification of liabilities.

The sudden reduction in reported debt levels suggests a potential change in capital structure strategy, yet the persistent negative retained earnings of $649.0M indicate that historical debt-fueled acquisitions have not yet generated sufficient equity value. Investors should monitor whether this deleveraging is sustainable or if it masks underlying liquidity constraints that could limit future operational flexibility.

Goodwill Concentration and Asset Quality

Based on the company's balance sheet data, goodwill remains a dominant asset at $2.6B, representing over 59% of total assets as of 2026Q1, which suggests that the firm's valuation is heavily dependent on the successful integration of past acquisitions rather than tangible, income-generating medical equipment.

The high proportion of intangible assets relative to the $795.1M in net PPE implies that the company's competitive position is tied to acquired market share rather than proprietary physical infrastructure. This concentration creates a significant risk of impairment charges should the acquired business units fail to meet their projected cash flow targets in the current regulatory environment.

Tight Liquidity and Working Capital

According to quarterly filings, the current ratio has tightened to 0.92 as of 2026Q1, indicating that the company's ability to cover short-term obligations with liquid assets has deteriorated compared to the 1.33 ratio observed in 2024Q1, signaling a potential narrowing of the firm's operational safety buffer.

The decline in the current ratio, coupled with a cash position of only $48.0M, suggests that the company may face challenges in managing its working capital requirements during periods of reimbursement delays. This liquidity profile appears increasingly fragile, necessitating a disciplined approach to cash management to avoid reliance on external financing for routine operations.

Erosion of Shareholder Equity Base

As evidenced by the company's reported figures, retained earnings have remained consistently negative, reaching -$649.0M in 2026Q1, which highlights a structural inability to build a sustainable equity base through organic profitability despite the company's extensive scale in the home medical equipment market.

The persistent deficit in retained earnings suggests that the capital allocation strategy has historically prioritized growth over the accumulation of shareholder value. This trend may indicate that the company's business model is currently optimized for market expansion rather than the generation of positive net income, leaving the equity base vulnerable to further erosion.

AHCO — Frequently Asked Questions

Quick answers to the most common questions about buying AHCO stock.

What are the total assets of AdaptHealth Corp. (AHCO)?

As of 2025, AdaptHealth Corp. (AHCO) had total assets of $4.32B including $728.9M in current assets.

How much debt does AdaptHealth Corp. (AHCO) have?

AdaptHealth Corp. (AHCO) carries total debt of $1.90B, offset by $106.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of AdaptHealth Corp.?

AdaptHealth Corp. (AHCO) has total shareholders' equity (book value) of $1.52B ($11.29 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is AdaptHealth Corp.'s current ratio and liquidity?

AdaptHealth Corp. (AHCO) reported a current ratio of 1.02x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.